Douglas W. Ball

10.6k total citations · 3 hit papers
93 papers, 7.1k citations indexed

About

Douglas W. Ball is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Douglas W. Ball has authored 93 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 39 papers in Molecular Biology and 34 papers in Oncology. Recurrent topics in Douglas W. Ball's work include Thyroid Cancer Diagnosis and Treatment (32 papers), Pituitary Gland Disorders and Treatments (10 papers) and Cancer-related Molecular Pathways (10 papers). Douglas W. Ball is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (32 papers), Pituitary Gland Disorders and Treatments (10 papers) and Cancer-related Molecular Pathways (10 papers). Douglas W. Ball collaborates with scholars based in United States, Italy and France. Douglas W. Ball's co-authors include Barry D. Nelkin, Stephen B. Baylin, Michael Borges, Virote Sriuranpong, Herbert Chen, Steven I. Sherman, Ezra E.W. Cohen, Manisha H. Shah, Lisa Licitra and Christopher J. Strock and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Douglas W. Ball

91 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cabozantinib in Progressive Medullary Thyroid Cancer

2013 850 citations Rossella Elisei, Martin Schlumberger et al. Journal of Clinical Oncology profile →
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis

2003 504 citations Anirban Maitra, Virote Sriuranpong et al. profile →
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer

2011 445 citations Razelle Kurzrock, Steven I. Sherman et al. Journal of Clinical Oncology profile →

Peers

Douglas W. Ball

ONCOL

EDM

EPIDE

SURGE

Francesca Carlomagno Italy

Barry D. Nelkin United States

Lois M. Mulligan Canada

Ludovic Lacroix France

Kennichi Kakudo Japan

Rosa Marina Melillo Italy

Italia Bongarzone Italy

Maria Luisa Carcangiu Italy

Angela Greco Italy

Catherine S. Healey United Kingdom

Francesca Carlomagno Italy

Douglas W. Ball

2.9k ×0.9

2.4k ×0.9

ONCOL

2.5k ×1.2

EDM

742 ×0.7

EPIDE

563 ×0.5

SURGE

Citations per year, relative to Douglas W. Ball Douglas W. Ball (= 1×) peers Francesca Carlomagno

Countries citing papers authored by Douglas W. Ball

Since Specialization

Citations

This map shows the geographic impact of Douglas W. Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Ball more than expected).

Fields of papers citing papers by Douglas W. Ball

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas W. Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Ball. The network helps show where Douglas W. Ball may publish in the future.

Co-authorship network of co-authors of Douglas W. Ball

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W. Ball. A scholar is included among the top collaborators of Douglas W. Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W. Ball. Douglas W. Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurzrock, Razelle, Douglas W. Ball, Marianna Zahurak, et al.. (2019). A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers. Clinical Cancer Research. 25(18). 5475–5484. 19 indexed citations

Schlumberger, Martin, Barbara Jarząb, Maria E. Cabanillas, et al.. (2015). A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer. Clinical Cancer Research. 22(1). 44–53. 184 indexed citations

Elisei, Rossella, Martin Schlumberger, Stefan Müller, et al.. (2013). Cabozantinib in Progressive Medullary Thyroid Cancer. Journal of Clinical Oncology. 31(29). 3639–3646. 850 indexed citations breakdown →

Jin, Ning, Tianyun Jiang, David Rosen, Barry D. Nelkin, & Douglas W. Ball. (2011). Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer. Clinical Cancer Research. 17(20). 6482–6489. 75 indexed citations

Feldmann, Georg, Anjali Mishra, Seung‐Mo Hong, et al.. (2010). Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral Signaling. Cancer Research. 70(11). 4460–4469. 138 indexed citations

Jin, Ning, Tianyun Jiang, Dina Rosen, Barry D. Nelkin, & Douglas W. Ball. (2009). Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 94(10). 4107–4112. 66 indexed citations

Jiang, Tianyun, Brendan Collins, Ning Jin, et al.. (2009). Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer. Cancer Research. 69(3). 845–854. 149 indexed citations

Strock, Christopher J., Jong‐In Park, Eric K. Nakakura, et al.. (2006). Cyclin-Dependent Kinase 5 Activity Controls Cell Motility and Metastatic Potential of Prostate Cancer Cells. Cancer Research. 66(15). 7509–7515. 128 indexed citations

Ball, Douglas W.. (2006). Medullary thyroid cancer: therapeutic targets and molecular markers. Current Opinion in Oncology. 19(1). 18–23. 65 indexed citations

10.

Ball, Douglas W., et al.. (2005). A Delicate Balance: Service-Learning in Teacher Education. SHILAP Revista de lepidopterología. 6 indexed citations

11.

Nakakura, Eric K., Virote Sriuranpong, Muthusamy Kunnimalaiyaan, et al.. (2005). Regulation of Neuroendocrine Differentiation in Gastrointestinal Carcinoid Tumor Cells by Notch Signaling. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4350–4356. 97 indexed citations

12.

Fan, Xing, Irina Mikolaenko, Ihab O. Elhassan, et al.. (2004). Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth. Cancer Research. 64(21). 7787–7793. 313 indexed citations

13.

Strock, Christopher J., Jong‐In Park, Mark Rosen, et al.. (2003). CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.. PubMed. 63(17). 5559–63. 83 indexed citations

14.

Sriuranpong, Virote, Michael Borges, Eric K. Nakakura, et al.. (2002). Notch Signaling Induces Rapid Degradation of Achaete-Scute Homolog 1. Molecular and Cellular Biology. 22(9). 3129–3139. 139 indexed citations

15.

Sriuranpong, Virote, Michael Borges, Rajani Ravi, et al.. (2001). Notch signaling induces cell cycle arrest in small cell lung cancer cells.. PubMed. 61(7). 3200–5. 374 indexed citations

16.

Linnoila, R. Ilona, Bei Zhao, Janet L. DeMayo, et al.. (2000). Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice.. PubMed. 60(15). 4005–9. 105 indexed citations

17.

Chen, Herbert, Michael Borges, Arunthathi Thiagalingam, et al.. (1997). Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.. PubMed. 8(6). 677–86. 51 indexed citations

18.

Chen, Herbert, Arunthathi Thiagalingam, Hemi Chopra, et al.. (1997). Conservation of the Drosophila lateral inhibition pathway in human lung cancer: A hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proceedings of the National Academy of Sciences. 94(10). 5355–5360. 237 indexed citations

19.

Thiagalingam, Arunthathi, A de Bustros, Michael Borges, et al.. (1996). RREB-1, a Novel Zinc Finger Protein, Is Involved in the Differentiation Response to Ras in Human Medullary Thyroid Carcinomas. Molecular and Cellular Biology. 16(10). 5335–5345. 123 indexed citations

20.

Campbell, Susan, et al.. (1996). Cell-substratum interactions mediate oncogene-induced phenotype of lung cancer cells.. PubMed. 7(9). 1149–56. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact